山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (12): 44-50.doi: 10.6040/j.issn.1671-7554.0.2023.0770
• 医学影像人工智能的创新与挑战—临床研究 • 上一篇 下一篇
朱正阳1,沈靖菲2,陈思璇1,叶梅萍1,杨惠泉1,周佳南1,梁雪1,张鑫1,张冰1
ZHU Zhengyang1, SHEN Jingfei2, CHEN Sixuan1, YE Meiping1, YANG Huiquan1, ZHOU Jianan1, LIANG Xue1, ZHANG Xin1, ZHANG Bing1
摘要: 目的 探讨磁敏感加权成像(SWI)不同影像组学模型术前预测胶质瘤异柠檬酸脱氢酶(IDH)突变状态的效能。 方法 回顾性分析加州大学旧金山分校弥漫性胶质瘤术前磁共振成像数据集(UCSF-PDGM)中经病理证实的493例成人弥漫性胶质瘤患者的影像资料,其中IDH野生型393例,IDH突变型100例,按照8∶2分为训练集(395例)和测试集(98例),根据数据集中提供的分割标签,在SWI序列上按照肿瘤核心(TC)和全肿瘤区(WT)两个感兴趣区(ROI)提取了共计1 316个影像组学特征,采用z-score法对特征进行标准化,通过主成分分析法进行降维,运用方差分析进行特征筛选,采用支持向量机(SVM)、线性判别分析(LDA)、自编码器(AE)、逻辑回归(LR)算法 、Lasso的逻辑回归算法(LR-Lasso)、贝叶斯分类器(NB)建模。通过受试者工作特征(ROC)曲线构建计算模型的准确率、敏感性、特异性,用测试集的曲线下面积(AUC)评估模型效能。 结果 20项影像组学特征被筛选用于建立影像组学诊断模型。SVM模型的AUC和准确率分别为0.841和0.755;LDA模型的AUC和准确率分别为0.800和0.735;AE模型的AUC和准确率分别为0.743和0.745;LR模型的AUC和准确率分别为0.842和0.725;LR-LASSO模型的AUC和准确率分别为0.880和0.857;NB模型的AUC和准确率分别为0.806和0.725。 结论 SWI影像组学特征在预测胶质瘤IDH基因突变中有一定的价值,基于LR-LASSO模型的预测效果最好。
中图分类号:
| [1] Schaff LR, Mellingoff I K. Glioblastoma and other primary brain malignancies in adults: a review [J]. JAMA, 2023, 329(7): 574-587. [2] Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary [J]. Neuro Oncol, 2021, 23(8): 1231-1251. [3] Pirozzi CJ, Yan H. The implications of IDH mutations for cancer development and therapy [J]. Nat Rev Clin Oncol, 2021, 18(10): 645-661. [4] Van-der-voort SR, Incekara F, Wijnenga MM J, et al. Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning [J]. Neuro Oncol, 2023, 25(2): 279-289. [5] Yang X, Hu C, Xing Z, et al. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI [J]. Eur Radiol, 2023, 33(10): 7003-7014. [6] Yang X, Xing Z, She D, et al. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging [J]. BMC Medical Imaging, 2022, 22(1): 105. doi: 10.1186/s12880-022-00832-3. [7] Kong LW, Chen J, Zhao H, et al. Intratumoral susceptibility signals reflect biomarker status in gliomas [J]. Sci Rep, 2019, 9(1): 17080. doi: 10.1038/s41598-019-53629-w. [8] 李欣, 谢继承, 王静, 等. 磁共振MRS、DWI及SWI序列在脑胶质瘤分级诊断中的应用价值[J]. 中华全科医学, 2022, 20(9): 1541-1544. LI Xin, XIE Jichen, WANG Jing, et al. The application value of magnetic resonance MRS, DWI and SWI sequences in the grading diagnosis of glioma [J]. Chinese Journal of General Practice, 2022, 20(9): 1541-1544. [9] Rudie JD, Rauschecker AM, Bryan RN, et al. Emerging applications of artificial intelligence in neuro-oncology [J]. Radiology, 2019, 290(3): 607-618. [10] Yan J, Zhang B, Zhang S, et al. Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients [J]. NPJ Precis Oncol, 2021, 5(1): 72. doi: 10.1038/s41698-021-00205-z. [11] Calabrese E, Villanueva-meyer JE, Rudie JD, et al. The university of california san francisco preoperative diffuse glioma MRI dataset [J]. Radiol Artif Intell, 2022, 4(6): e220058. doi: 10.1148/ryai.220058. [12] Clark K, Vendt B, Smith K, et al. The cancer imaging archive(TCIA): maintaining and operating a public information repository [J]. J Digit Imaging, 2013, 26(6): 1045-1057. [13] Song Y, Zhang J, Zhang YD, et al. FeAture explorer(FAE): a tool for developing and comparing radiomics models [J]. PLoS One, 2020, 15(8): e0237587. doi: 10.1371/journal.pone.0237587. [14] 涂佳琪, 朱凤平, 李郁欣. 磁敏感加权成像在脑胶质瘤诊疗中的应用进展[J]. 国际医学放射学杂志, 2023, 46(4): 414-416. TU Jiaqi, ZHU Fengping, LI Yuxin. Advances in the application of susceptibility-weighted imaging in the diagnosis and treatment of brain gliomas [J]. International Journal of Medical Radiology, 2023, 46(4): 414-416. [15] Lin Y, Xing Z, She D, et al. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI [J]. Neuroradiology, 2017, 59(6): 555-562. [16] Saini J, Gupta PK, Sahoo P, et al. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging [J]. Neuroradiology, 2018, 60(1): 43-50. [17] 杜常月, 齐旭红, 温智勇, 等. SWI、3D-ASL及IVIM鉴别高低级别脑胶质瘤的研究[J]. 中国CT和MRI杂志, 2023, 21(1): 9-11. DU Changyue, QI Xuhong, WEN Zhiyong, et al. The study of SWI, 3D-ASL and IVIM in distinguishing high and low grade glioma [J]. Chinese Journal of CT and MRI, 2023, 21(1): 9-11. [18] Yang X, Lin Y, Xing Z, et al. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas [J]. Acta Radiol, 2021, 62(12): 1657-1665. [19] Natsumeda M, Matsuzawa H, Watanabe M, et al. SWI by 7T MR Imaging for the microscopic imaging diagnosis of astrocytic and oligodendroglial tumors [J]. AJNR Am J Neuroradiol, 2022, 43(11): 1575-1581. [20] Kihira S, Mei X, Mahmoudi K, et al. U-net based segmentation and characterization of gliomas [J]. Cancers(Basel), 2022, 14(18): 4457. doi: 10.3390/cancers14184457. [21] 宋珍珍, 孙小玲, 李海鸥, 等. 120例胶质瘤及瘤周水肿MRI影像组学在评估肿瘤复发中的价值[J]. 山东大学学报(医学版), 2021, 59(11): 53-60. SONG Zhenzhen, SUN Xiaoling, LI Haiou, et al. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University(Health Sciences), 2021, 59(11): 53-60. [22] 袁宏涛, 纪淙山, 康冰, 等. CT影像组学对肾上腺乏脂腺瘤与结节样增生的诊断价值[J]. 山东大学学报(医学版), 2022, 60(4): 68-75. YUAN Hongtao, JI Congshan, KANG Bing, et al. Diagnostic value of CT radiomics nomogram for adrenal lipid-poor adenoma and nodular hyperplasia [J]. Journal of Shandong University(Health Sciences), 2022, 60(4): 68-75. [23] Li Y, Ammari S, Lawrance L, et al. Radiomics-based method for predicting the glioma subtype as defined by tumor grade, IDH mutation, and 1p/19q codeletion [J]. Cancers(Basel), 2022, 14(7):1778. doi: 10.3390/cancers14071778. [24] Li Y, Wei D, Liu X, et al. Molecular subtyping of diffuse gliomas using magnetic resonance imaging: comparison and correlation between radiomics and deep learning [J]. Eur Radiol, 2022, 32(2): 747-758. [25] Xiong D, Ren X, Huang W, et al. Noninvasive classification of glioma subtypes using multiparametric MRI to improve deep learning [J]. Diagnostics(Basel), 2022, 12(12):3063. doi: 10.3390/diagnostics12123063. |
| [1] | 王琳琳 孙美丽 孙玉萍 张楠 刘传勇. 中心体α-微管蛋白、γ-微管蛋白在脑胶质瘤中的表达及其与Survivin表达的相关性研究[J]. 山东大学学报(医学版), 2209, 47(6): 103-. |
| [2] | 廖原,门丹,李一帆,李怀臣,龙飞,刘铱. PM2.5短期暴露对结核病发病风险的个体精准评估[J]. 山东大学学报 (医学版), 2026, 64(3): 116-123. |
| [3] | 刘禹,霍娅娅,龚丞,梁婷,李斌. 基于机器学习的骨科生物材料设计与优化[J]. 山东大学学报 (医学版), 2026, 64(2): 22-33. |
| [4] | 王建民,李晓峰,由志涛,董圣杰,赵宇驰,李占菊,邹德鑫,张剑锋,孙涛,杜伟. 基于可解释机器学习的后路腰椎椎体间融合术后慢性疼痛风险预测模型构建[J]. 山东大学学报 (医学版), 2026, 64(2): 78-88. |
| [5] | 王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54. |
| [6] | 王丽云,高天勤,刘雨佳,陈青,陈柳,沙凯辉. 基于机器学习产后压力性尿失禁风险预测模型的构建及验证[J]. 山东大学学报 (医学版), 2025, 63(6): 55-66. |
| [7] | 刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72. |
| [8] | 孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80. |
| [9] | 李永,崔书君,杨飞,张凡,殷晓霞. 基于增强MRI的亚区域影像组学模型可预测乳腺癌患者新辅助化疗后的病理完全反应[J]. 山东大学学报 (医学版), 2025, 63(1): 81-89. |
| [10] | 卢晓颂,杨瑞敏,王义成,周海丰,罗兵,李晓宇,李娜娜. 含瘤周组织的超声影像组学在鉴别乳腺结节良恶性中的价值[J]. 山东大学学报 (医学版), 2025, 63(1): 90-98. |
| [11] | 王静,刘晓菲,曾荣,许长娟,张锦涛,董亮. 基于机器学习算法鉴定哮喘的坏死性凋亡相关生物标志物[J]. 山东大学学报 (医学版), 2024, 62(7): 21-32. |
| [12] | 郭振江,王宁,赵光远,杜立强,崔朝勃,刘防震. 基于机器学习建立术前预测近端胃癌食管切缘阳性模型[J]. 山东大学学报 (医学版), 2024, 62(7): 78-83. |
| [13] | 郭姝画,樊扬,田风,王传新,杜鲁涛,李培龙,郭兴,徐硕. 微原纤维相关蛋白3在调控胶质瘤干细胞间充质表型转化中的作用[J]. 山东大学学报 (医学版), 2024, 62(6): 9-16. |
| [14] | 梁永媛,蔡培飞,郑桂喜. 基于多检验变量和机器学习算法的结肠癌诊断模型建立及价值评估[J]. 山东大学学报 (医学版), 2024, 62(2): 51-59. |
| [15] | 王玉涛,孙岩. 单细胞转录组学与机器学习综合分析揭示腹主动脉瘤潜在生物标志物[J]. 山东大学学报 (医学版), 2024, 62(11): 40-53. |
|
||